A continuation of our Pre-Budget Forecast 2026 series, Part 2 dives deeper into market triggers, sector risks, historical behaviour, and a disciplined retail investor playbook before Budget Day.
India Pre-Budget Forecast 2026 (Part – 2): The Fine Print Investors Should Track Read More »
A detailed breakdown of Q3 FY26 pharma results covering Cipla, Dr Reddy’s Laboratories and Laurus Labs with key factors, CMP, fundamentals, technical view and management commentary.
India’s major banking stocks have announced strong Q3 FY26 results. Here’s a detailed breakdown of HDFC Bank, ICICI Bank, Kotak Mahindra Bank and Bank of India covering profits, growth, fundamentals, management outlook and technical levels.
GLP-1 medications are reshaping weight loss and nutrition in 2026. Learn how they influence appetite, metabolism, diet choices, and long-term health—safely.
India’s Union Budget 2026 is around the corner. This detailed pre-budget forecast covers market outlook, sector-wise expectations, stocks in focus, historical trends, and how retail investors should position with a risk-managed approach.
Pre-Budget Market Outlook (Union Budget 2026-27) — What the Market Is Pricing In Read More »
A beginner-friendly guide to IPOs explaining the application process, allotment rules, DRHP basics, and listing day risks with realistic expectations.
Stock Market 101–Lesson 14 IPOs for Beginners: Process & Allotment Basics Read More »
